ABT Stock Analysis: Buy, Sell, or Hold?
ABT - Abbott Laboratories
$90.53
2.70 (3.07%)
▲
5d:
+2.1%
30d:
+3.14%
90d:
-13.66%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 16, 2026
21d
Smart Money Accumulation
None View Scanner →
Strength: 8.0/10
Get Alerted When ABT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 5.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ABT shows positive signals but monitor for confirmation. Market pricing in 5.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$152.01
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$94.39
4.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABT is currently trading at $90.53, which is considered extended relative to its 30-day fair value range of $86.53 to $90.07. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.9) compared to its historical average (17.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is approaching resistance at $92.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ABT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.54 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABT is in a strong downtrend. The price is approaching resistance at $92.02. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: ABT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $116.54 (+28.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$86.53 -
$90.07
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 28.7% below Wall St target ($116.54)
Trading Range Analysis
30-Day Trading Range
$86.53 -
$90.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$87.07
Resistance Level
$92.02
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.94
Wall Street Target
$116.54
(+28.7%)
Revenue Growth (YoY)
7.8%
Earnings Growth (YoY)
-19.7%
Profit Margin
13.9%
Valuation Discount vs History
-5.5% cheaper
PE vs Historical
14.9 vs 17.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.5%
(market-implied from PE analysis)
1-Year Target
$85.55
(-6%)
2-Year Target
$80.85
(-11%)
3-Year Target
$76.40
(-16%)
3-Yr Target (if PE normalizes)
(PE: 15→18)
$90.51
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.5%)
$178.08
(+97%)
Base:
(SPY PE: 14.9, Growth: 10.5%)
$122.16
(+35%)
Bear:
(PE: 12.7, Growth: 10.5%)
$103.84
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 24.60 | Current EPS (TTM): $3.57
Bull Case
$163.98
(+81%)
Analyst growth 69.7%, PE expands to 27.1
Base Case
$149.07
(+65%)
Market implied 69.7%, PE stable at 24.6
Bear Case
$59.72
(-34%)
Severe decline -20.0%, PE contracts to 20.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.9 to 17.7
Stabilization Target:
$107.25
(+18.5%)
PE Expansion Potential:
+18.5%
Share & Embed Analysis
Last updated: June 24, 2026 1:25 AM ET
Data refreshes hourly during market hours. Next update: 2:25 AM
Data refreshes hourly during market hours. Next update: 2:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABT showing a specific setup today?
Insider Activity (6 Months)
7
Buys
13
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Laura Friedman
SELL
2026-03-24
Ro Khanna
BUY
2026-03-23
Featured in Portfolios
ABT is a key holding in these high-performance investment strategies.
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
Advanced ABT Option Strategies
Professional options setups generated by AI based on today's ABT price and gamma walls.
